Artivion, Inc. (AORT)
26.32
-0.77
(-2.84%)
USD |
NYSE |
Sep 02, 16:00
26.32
0.00 (0.00%)
After-Hours: 20:00
Artivion Research and Development Expense (TTM) : 35.10M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 35.10M |
| March 31, 2026 | 33.10M |
| December 31, 2025 | 30.99M |
| September 30, 2025 | 29.27M |
| June 30, 2025 | 27.80M |
| March 31, 2025 | 28.23M |
| December 31, 2024 | 28.45M |
| September 30, 2024 | 28.69M |
| June 30, 2024 | 28.51M |
| March 31, 2024 | 28.43M |
| December 31, 2023 | 28.71M |
| September 30, 2023 | 29.37M |
| June 30, 2023 | 34.74M |
| March 31, 2023 | 35.97M |
| December 31, 2022 | 38.88M |
| September 30, 2022 | 40.04M |
| June 30, 2022 | 38.21M |
| March 31, 2022 | 37.92M |
| December 31, 2021 | 35.55M |
| September 30, 2021 | 32.66M |
| June 30, 2021 | 28.44M |
| March 31, 2021 | 25.60M |
| December 31, 2020 | 24.21M |
| September 30, 2020 | 22.94M |
| June 30, 2020 | 23.45M |
| Date | Value |
|---|---|
| March 31, 2020 | 23.77M |
| December 31, 2019 | 22.96M |
| September 30, 2019 | 24.43M |
| June 30, 2019 | 23.40M |
| March 31, 2019 | 23.28M |
| December 31, 2018 | 23.10M |
| September 30, 2018 | 22.68M |
| June 30, 2018 | 21.73M |
| March 31, 2018 | 20.74M |
| December 31, 2017 | 19.46M |
| September 30, 2017 | 16.94M |
| June 30, 2017 | 16.38M |
| March 31, 2017 | 14.93M |
| December 31, 2016 | 13.45M |
| September 30, 2016 | 12.14M |
| June 30, 2016 | 11.39M |
| March 31, 2016 | 10.79M |
| December 31, 2015 | 10.44M |
| September 30, 2015 | 9.988M |
| June 30, 2015 | 8.93M |
| March 31, 2015 | 8.449M |
| December 31, 2014 | 8.699M |
| September 30, 2014 | 9.085M |
| June 30, 2014 | 9.435M |
| March 31, 2014 | 8.968M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Alphatec Holdings, Inc. | 76.69M |
| Globus Medical, Inc. | 147.06M |
| Glaukos Corp. | 177.17M |
| TransMedics Group, Inc. | 92.47M |
| PROCEPT BioRobotics Corp. | 77.19M |